Rheumatoid Arthritis Clinical Trials in Philadelphia

Showing 1481-1500 of 3,347 trials

Research Study to Determine Sensitivity to Gentle Touch and Pressure During an Active Migraine Attack.

NCT00329771

Cutaneous allodynia (pronounced q-tane-ee-us all-o-din-ee-a) is common in migraine. It is a heightened skin sensitivity during an active migraine attack. Migraine attacks in patients who experience allodynia are more difficult to treat. This study intends to collect and evaluate data on the phenomenon of allodynia in patients with episodic migraine during an actual attack. The results of this study may help clinicians better understand allodynia, thereby helping them diagnose and more effectively manage patients with migraine and allodynia.

Migraine

Thomas Jefferson University28 participantsStarted Mar 2006

Philadelphia, Pennsylvania, United States

COMPLETEDPhase 2< 1 mile

A Study of Mirikizumab (LY3074828) in Children and Teenagers With Ulcerative Colitis (UC)

NCT04004611

This study was designed to evaluate how the body processes and removes mirikizumab. The study also evaluated safety and disease response in pediatric participants with UC taking mirikizumab. The study lasted about 52 weeks and included up to 18 visits.

Ulcerative Colitis

Eli Lilly and Company26 participantsStarted May 2020

Orange, California, United States • San Francisco, California, United States • Denver, Colorado, United States +34 more locations

Research Study to Determine Sensitivity to Gentle Touch and Pressure During an Active Migraine Attack.

A Study of Mirikizumab (LY3074828) in Children and Teenagers With Ulcerative Colitis (UC)

Rheumatoid Arthritis Trials in Other Cities

Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission

Teen Adherence in KidnEy Transplant Improving Tracking To Optimize Outcomes - Stage 3

Study to Evaluate Amifampridine Phosphate in Patients With MuSK-MG

Long-term Access Program (LAP) of Mepolizumab for Subjects Who Participated in Study MEA115921

ReCoUPS: Post-Concussion Patient Reports

Chemotherapy Induced Peripheral Neuropathy Natural History Study (EPIPHANY)

OCS Lung System EXPAND II Trial

Dose-finding Study of SPK-8016 Gene Therapy in Patients With Hemophilia A to Support Evaluation in Individuals With FVIII Inhibitors

Treatment of Impulsive Aggression in Subjects With ADHD in Conjunction With Standard ADHD Treatment (CHIME 2)

Oral Infigratinib for the Adjuvant Treatment of Subjects With Invasive Urothelial Carcinoma With Susceptible FGFR3 Genetic Alterations

Reducing Opioid Use and Misuse After Wisdom Molar Extractions

Ibuprofen Inhibits Human Sweet Taste

A Phase 1, Open-Label, Dose-Escalation & Expanded Cohort, Continuous IV Infusion, Multi-center Study of the Safety, Tolerability,PK & PD of EPZ-5676 in Treatment Relapsed/Refractory Patients With Leukemias Involving

Melody Transcatheter Pulmonary Valve Study: Post Approval Study of the Investigational Device Exemption Cohort

Study of Tazemetostat as Single Agent in Solid Tumors or B-cell Lymphomas and in Combination With Prednisolone in DLBCL

A Comparative Study Between PF-06410293 and Humira® in Combination With Methotrexate in Participants With Active Rheumatoid Arthritis

The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)

Platform Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With aOX40 (GSK3174998) in Participants With RRMM

Other Conditions in Philadelphia